Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 2/20 | 1.00 |
| ▸ | LCK | P06239 | 1/20 | 0.62 |
| ▸ | PPARD | Q03181 | 1/20 | 0.62 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.62 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 4/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9654828 | 1.00 | ZDHHC7 (1.00) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL9642099 | 1.00 | ZDHHC7 (1.00) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL7760363 | 1.00 | ZDHHC7 (1.00) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL10979746 | 1.00 | ZDHHC7 (1.00) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL2817825 | 1.00 | ZDHHC7 (1.00) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL1566194 | 0.98 | ZDHHC7 (0.96) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL873757 | 0.92 | ZDHHC7 (0.85) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL7951119 | 0.92 | ZDHHC7 (0.85) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL27837692 | 0.92 | ZDHHC7 (0.84) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 | |
| Dodecanoate SCHEMBL28459049 | 0.90 | ZDHHC7 (0.81) | ZDHHC7LCKPPARDZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105498623-B | Viscoelastic solution prepared with negative ion dimeric surfactant 16-S-16 as raw material and preparation method and application of negative ion dimeric surfactant 16-S-16 | 宁德师范学院 | 2017-05-24 | — | — | CN | claimed |
| CN-103910738-B | A kind of Bisbenzylisoquinolincompounds quaternary ammonium salt and preparation method thereof and the application in preparing antitumor drug | 山东师范大学 | 2016-07-06 | — | — | CN | claimed |
| CN-105498623-A | Viscoelastic solution prepared with negative ion dimeric surfactant 16-S-16 as raw material and preparation method and application of negative ion dimeric surfactant 16-S-16 | UNIV NINGDE NORMAL | 2016-04-20 | — | — | CN | claimed |
| CN-103910741-B | Bisbenzylisoquinolincompounds trimethyl-glycine and preparation method thereof and the application in antitumor drug preparation | Shangdong Normal University (CN) | 2016-04-13 | — | — | CN | claimed |
| US-12416036-B2 | High-throughput enzyme assay for screening activity of acyltransferases | CORNELL UNIVERSITY (US) | 2025-09-16 | — | — | US | disclosed |
| US-20220403443-A1 | HIGH-THROUGHPUT ENZYME ASSAY FOR SCREENING ACTIVITY OF ACYLTRANSFERASES | CORNELL UNIVERSITY | 2022-12-22 | — | — | US | disclosed |
| EP-3000482-B1 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | NOVO NORDISK AS (DK) | 2021-04-21 | — | — | EP | disclosed |
| CN-104311657-B | Double acylated GLP-1 derivatives | 诺沃—诺迪斯克有限公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-111560060-A | Double acylated GLP-1 derivatives | 诺沃—诺迪斯克有限公司 | 2020-08-21 | — | — | CN | disclosed |
| CN-104327182-B | Double acylated GLP-1 derivatives | 诺沃—诺迪斯克有限公司 | 2020-04-17 | — | — | CN | disclosed |
| US-10428302-B2 | Alkaline microbial enhanced oil recovery | GEO FOSSIL FUELS, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| EP-3211068-A1 | ALKALINE MICROBIAL ENHANCED OIL RECOVERY | Geo Fossil Fuels, LLC (US) | 2017-08-30 | — | — | EP | disclosed |
| US-20100028939-A1 | Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest | NOVO NORDISK HEALTHCARE A/G (CH) | 2010-02-04 | — | — | US | disclosed |
| US-6482850-B2 | TAXANE WITH A HYDROCARBON HAVING AT THE ALPHA POSITION A GROUP SUCH AS HALOGEN AT THE 2' AND/OR 7 POSITIONS; ENHANCED IN VIVO HYDROLYSIS FOR ENHANCED TAXANE THERAPEUTIC ACTIVITY | THE LIPOSOME COMPANY | 2002-11-19 | — | — | US | disclosed |
| US-6392063-B1 | ANTICANCER DRUG | THE LIPOSOME COMPANY, INC. | 2002-05-21 | — | — | US | disclosed |
| US-20020052518-A1 | Hydrolysis-promoting hydrophobic taxane derivatives | CEPHALON LIMITED (GB) | 2002-05-02 | — | — | US | disclosed |
| US-6107332-A | ANTICANCER AGENTS; ANTIINFLAMMATORY AGENTS | THE LIPOSOME COMPANY, INC. (US) | 2000-08-22 | — | — | US | disclosed |
| EP-0356154-B1 | Trehalose derivatives | SAWAI SEIYAKU KK (JP) | 1997-04-09 | — | — | EP | disclosed |
| US-5049664-A | Antitumor agents | SAWAI PHARMACEUTICAL CO., LTD. (JP) | 1991-09-17 | — | — | US | disclosed |
| EP-0356154-A2 | Trehalose derivatives | SAWAI PHARMACEUTICAL CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052518-A1 | Hydrolysis-promoting hydrophobic taxane derivatives | HPN, MMP8, HPGDS | ZDHHC7 1111/4885LCK 4481/4885PPARD 1134/4885 |
| US-20100028939-A1 | Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic Interest | GALE, GALNT2, GALNT1 | ZDHHC7 927/4885LCK 3729/4885PPARD 3117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.